Publications by authors named "G Block"

Understanding and incorporating evidence-based veterinary medicine (EBVM) into clinical practice and research continues to pose a challenge for our profession despite over 2 decades of increasing awareness of this concept. Reasons for this include a lack of understanding of its importance to the practice of medicine, veterinary literature that often fails to adhere to evidence-based standards, inadequate attention to teaching EBVM at the university level, and the inherent reluctance of clinicians to alter historical practice styles. For many practitioners, EBVM continues to be an abstract concept they believe requires advanced training in statistics and epidemiology resulting in them relying on less robust sources for clinical guidance.

View Article and Find Full Text PDF

Importance: Integrating routine SARS-CoV-2 testing in dialysis facilities may benefit patients receiving dialysis by mitigating risks of serious illness and reducing transmission. Patient acceptance of nonmandatory testing is unknown.

Objective: To evaluate the acceptance of 2 SARS-CoV-2 testing strategies among patients in hemodialysis facilities nationwide.

View Article and Find Full Text PDF

Key Points: No correlation was observed between pruritus severity and serum phosphate or response to placebo or difelikefalin in patients with CKD-associated pruritus undergoing hemodialysis. Difelikefalin improved itch versus placebo irrespective of baseline serum phosphate.

Background: CKD-associated pruritus (CKD-aP) has historically been associated with elevated serum phosphate (sP).

View Article and Find Full Text PDF
Article Synopsis
  • Ferric citrate (FC) is a phosphate binder for dialysis patients with chronic kidney disease, and this study examined its effects on the use of erythropoiesis-stimulating agents (ESAs) and IV iron.
  • In a study involving over 200 dialysis patients, those treated with FC showed a significant reduction in monthly ESA doses compared to those on standard care, while showing non-significant changes in IV iron doses.
  • Patients receiving FC also saw improvements in hemoglobin and other blood measures, and experienced fewer serious adverse events compared to those receiving standard therapy.
View Article and Find Full Text PDF